News Roundup: May 9 to May 13
Your weekly roundup of the latest news from Drug Topics®.
How Socioeconomic Factors Can Impact Depression Treatment
Home environments have a clear impact on depression treatment outcomes.
Are COVID-19 Rapid Tests Capable of Detecting Variants of Concern?
Investigators examined whether rapid antigen tests were less sensitive to variants of concern. Though the tests detected Omicron, all but 1 were less effective in detecting the Delta variant.
The Link Between Food Insecurity in Young Adulthood and Obesity, Diabetes Risk Later in Life
An analysis of data from more than 3500 individuals followed for more than 20 years provides insight into the impact of food insecurity on risk of cardiometabolic conditions, including obesity and type 2 diabetes.
A Look at Drug-Drug Interactions in Patients with Bipolar Disorder
Up to 20% of patients with bipolar disorder have 4 or more medications, so it is important to be aware of these common drug-drug interactions.
Many Biologics for Severe Asthma Can Be Self-Administered at Home — Patients Prefer It
Xolair (omalizumab), Fasenra (benralizumab), Dupixent (dupilumab) and Nucala (mepolizumab) can now be self-administered.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
